Sponsored by:

Nuclear Medicine: Page 305

Dilon rolls out new collimators
By AuntMinnie.com staff writers
Scintimammography developer Dilon Technologies has released two new collimators: the Slant15 Collimator for breast imaging and the Low Energy High-Resolution collimator.
February 2, 2009
FDA clears SNM IND application
By AuntMinnie.com staff writers
Nuclear medicine organization SNM said that the U.S. Food and Drug Administration (FDA) has approved an SNM-sponsored, multicenter investigational new drug (IND) application for F-18-labeled 3'-deoxy-3'-fluorothymidine.
February 2, 2009
Molecular Insight shuffles management
By AuntMinnie.com staff writers
Radiopharmaceutical developer Molecular Insight Pharmaceuticals has made a number of senior management appointments.
February 1, 2009
FDG-PET/CT improves detection of breast cancer
By AuntMinnie.com staff writers
Using FDG-PET/CT, researchers at the University of Texas M. D. Anderson Cancer Center identified the precise location and extent of metastasis in the initial staging of inflammatory breast cancer.
February 1, 2009
ACR Image Metrix chosen as AMI's CRO
By AuntMinnie.com staff writers
The American College of Radiology's (ACR) Image Metrix division in Philadelphia has been selected by the Academy of Molecular Imaging (AMI) as its contract research organization (CRO).
January 28, 2009
Report: Canada's isotope supply 'fragile'
By AuntMinnie.com staff writers
The U.S. isn't the only North American country sending warnings about the tenuous supply of medical isotopes. Canadian officials describe the problem as "critical" in a report published in the British journal Nature.
January 28, 2009
Neusoft Positron files 510(k) for Attrius
By AuntMinnie.com staff writers
Positron joint venture Neusoft Positron Medical Systems in Shenyang, China, has submitted a 510(k) application to the U.S. Food and Drug Administration for its Attrius cardiac PET scanner product line.
January 28, 2009
Covidien, B&W to tackle medical isotope dilemma
By Wayne Forrest
A radiopharmaceutical company and a firm that manages nuclear reactor facilities are pairing up to address one of the thorniest problems in medical imaging: securing a stable, U.S.-based source for medical radioisotopes.
January 27, 2009
2009 01 27 15 41 57 86 Nuclear Reactor 70
SPECT MPI works for CAD, Lantheus says
By AuntMinnie.com staff writers
Lantheus Medical Imaging said that a new study published in the January/February 2009 issue of the Journal of Nuclear Cardiology finds that the use of SPECT myocardial perfusion imaging (MPI) with its Cardiolite radiopharmaceutical is useful for diagnosing coronary artery disease (CAD) in patients with new-onset heart failure.
January 26, 2009
FluoroPharma nets patent for cardiovascular plaque
By AuntMinnie.com staff writers
Imaging agent developer FluoroPharma of Boston has received a U.S. patent for imaging cardiovascular plaque.
January 26, 2009
Covidien and B&W to develop isotope technology
By AuntMinnie.com staff writers
Radiopharmaceutical firm Covidien and Babcock & Wilcox (B&W) Technical Services Group will collaborate to develop reactor technology for the manufacture of the medical isotope molybdenum-99.
January 25, 2009
Eckert & Ziegler acquires Nuclitec
By AuntMinnie.com staff writers
Radiotherapy and radiopharmaceutical developer Eckert & Ziegler Strahlen-und Medizintechnik has acquired Nuclitec and its two French and U.S. affiliates.
January 25, 2009
Previous Page
Page 305 of 437
Next Page